Modern cytoprotective drugs (antihypoxants, antioxidants): what is the phenomenon of popularity in cardiology and neurology?

February 15, 2017

The article describes the possibilities and perspectives of modern cytoprotectors, in particular Cytoflavin®, in the complex therapy of hypoxic brain states of various etiologies and the results of the study of its clinical effectiveness. Based on the literature data about the effectiveness of this drug in treatment of patients with acute and chronic cardiovascular diseases, it was concluded the feasibility of its use as an important component of pathogenetic therapy of these disorders.

Key words: cytoprotectors, cardiovascular disease, Cytoflavin®.

Published: 15.02.2017